Is Lexapro (escitalopram) an antihistaminergic drug?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Is Lexapro Antihistaminergic?

No, Lexapro (escitalopram) is not an antihistaminergic drug—it has no or very low affinity for histamine receptors.

Receptor Binding Profile

Escitalopram has no or very low affinity for histamine H1, H2, and H3 receptors. 1 The FDA-approved drug label explicitly states that escitalopram "has no or very low affinity for serotonergic (5-HT1-7) or other receptors including alpha- and beta-adrenergic, dopamine (D1-5), histamine (H1-3), muscarinic (M1-5), and benzodiazepine receptors." 1

Mechanism of Action

  • Escitalopram functions as a highly selective serotonin reuptake inhibitor (SSRI) with its therapeutic effect linked to potentiation of serotonergic activity in the CNS through inhibition of serotonin reuptake. 1

  • The drug is at least 100-fold more potent than its R-enantiomer in inhibiting serotonin reuptake, with minimal effects on norepinephrine and dopamine neuronal reuptake. 1

  • Escitalopram is specifically six times less potent than citalopram in binding to histamine H1 and muscarinic receptors, meaning it has essentially negligible antihistaminergic activity. 2

Clinical Significance

The lack of antihistaminergic activity is clinically advantageous. The FDA label notes that "antagonism of muscarinic, histaminergic, and adrenergic receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular side effects of other psychotropic drugs." 1 By avoiding histamine receptor antagonism, escitalopram avoids the sedation, cognitive impairment, and weight gain commonly seen with antihistaminergic antidepressants.

Important Caveat: Histamine Reuptake Inhibition

While escitalopram does not block histamine receptors, recent research demonstrates that escitalopram can inhibit histamine reuptake as an off-target effect. 3 This mechanism becomes clinically relevant during inflammation, where increased histamine activity can impair escitalopram's ability to increase extracellular serotonin levels. 3 However, this represents histamine transporter inhibition, not antihistaminergic (receptor blocking) activity.

Contrast with True Antihistaminergic Antidepressants

For comparison, medications with genuine antihistaminergic properties include:

  • Doxepin: A potent H1 and H2 antihistamine with tricyclic antidepressant activity 4
  • Hydroxyzine: A first-generation H1 antihistamine 4
  • Cyproheptadine: A sedating H1 antihistamine with antiserotonergic activity 4

These agents cause sedation, cognitive decline (particularly in elderly patients), and anticholinergic effects—side effects notably absent with escitalopram due to its lack of histamine receptor affinity. 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.